Researcher.Life Logo

Therapeutic Advances in Vaccines and Immunotherapy : Impact Factor & More

eISSN: 2515-1363pISSN: 2515-1355
JournalOpen Access

Key Metrics

CiteScore
6.5
H-Index
10
SJR
Q2Oncology
SNIP
1.11
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Therapeutic Advances in Vaccines and Immunotherapy

Therapeutic Advances in Vaccines and Immunotherapy Journal Specifications

Indexed in the following public directories

  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher SAGE
Language English
Publication Time8
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
Website URLVisit website
Publication Details
Other chargesVisit website
PlagiarismVisit website
Publication Time 8
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY, CC BY-NC
OA statementVisit website
View less

Planning to publish in Therapeutic Advances in Vaccines and Immunotherapy ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Therapeutic Advances in Vaccines and Immunotherapy

Rabies post-exposure prophylaxis in India: a SWOT analysis
  • 2 Jan 2026
  • Therapeutic Advances in Vaccines and Immunotherapy
Exploring supplemental immunization strategies to reach zero-dose children in low- and middle-income countries: a scoping review.
  • 1 Jan 2026
  • Therapeutic advances in vaccines and immunotherapy
Exploring the safety and immunogenicity of the VLA15 vaccine among healthy or high-risk population: a systematic review and meta-analysis of randomized controlled trials
  • 1 Oct 2025
  • Therapeutic Advances in Vaccines and Immunotherapy
The urgent need for a licensed dengue vaccine in the Philippines
  • 23 Sep 2025
  • Therapeutic Advances in Vaccines and Immunotherapy
Uptake of human papillomavirus vaccination and associated factors among high school female students in Dessie City Administration, North East Ethiopia: a cross-sectional study
  • 1 Sep 2025
  • Therapeutic Advances in Vaccines and Immunotherapy
Immunization safety monitoring: addressing vaccine hesitancy and enhancing coverage in crisis-affected regions—insights from Lebanon, Ukraine, and Sudan
  • 1 Sep 2025
  • Therapeutic Advances in Vaccines and Immunotherapy
Rabies post-exposure prophylaxis in India: a SWOT analysis
  • 2 Jan 2026
  • Therapeutic Advances in Vaccines and Immunotherapy
Exploring supplemental immunization strategies to reach zero-dose children in low- and middle-income countries: a scoping review.
  • 1 Jan 2026
  • Therapeutic advances in vaccines and immunotherapy
Exploring the safety and immunogenicity of the VLA15 vaccine among healthy or high-risk population: a systematic review and meta-analysis of randomized controlled trials
  • 1 Oct 2025
  • Therapeutic Advances in Vaccines and Immunotherapy
The urgent need for a licensed dengue vaccine in the Philippines
  • 23 Sep 2025
  • Therapeutic Advances in Vaccines and Immunotherapy
Uptake of human papillomavirus vaccination and associated factors among high school female students in Dessie City Administration, North East Ethiopia: a cross-sectional study
  • 1 Sep 2025
  • Therapeutic Advances in Vaccines and Immunotherapy
Immunization safety monitoring: addressing vaccine hesitancy and enhancing coverage in crisis-affected regions—insights from Lebanon, Ukraine, and Sudan
  • 1 Sep 2025
  • Therapeutic Advances in Vaccines and Immunotherapy

FAQs on Therapeutic Advances in Vaccines and Immunotherapy